Clinical Trials Directory

Trials / Conditions / Stage IIIC Gastric Cancer

Stage IIIC Gastric Cancer

19 registered clinical trials studyying Stage IIIC Gastric Cancer.

StatusTrialSponsorPhase
UnknownNab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer
NCT04781413
Ruijin HospitalPhase 1 / Phase 2
CompletedHealth Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
NCT03154190
Stanford UniversityN/A
WithdrawnTalazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery an
NCT02567396
National Cancer Institute (NCI)Phase 1
CompletedElectronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in P
NCT02511821
City of Hope Medical CenterN/A
WithdrawnC-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced
NCT02344810
Eastern Cooperative Oncology GroupPhase 1 / Phase 2
SuspendedGenetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advan
NCT02366819
University of ChicagoPhase 4
Completed64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer
NCT01939275
City of Hope Medical CenterN/A
CompletedFamily Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe
NCT01846520
City of Hope Medical CenterN/A
CompletedPilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esop
NCT01612546
City of Hope Medical CenterPhase 2
TerminatedAkt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Meta
NCT01705340
National Cancer Institute (NCI)Phase 1
CompletedGenotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointest
NCT01643499
University of ChicagoPhase 1
CompletedBevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal
NCT01212822
Fox Chase Cancer CenterPhase 2
CompletedPralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gast
NCT01178944
Roswell Park Cancer InstitutePhase 2
CompletedIrinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophag
NCT00991952
National Cancer Institute (NCI)Phase 2
CompletedCombination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastr
NCT00982592
National Cancer Institute (NCI)Phase 2
CompletedIrinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroe
NCT00084604
National Cancer Institute (NCI)Phase 2
CompletedPhase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carc
NCT00084617
National Cancer Institute (NCI)Phase 2
TerminatedA Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer
NCT00064259
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedBortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Sto
NCT00061932
National Cancer Institute (NCI)Phase 2